A detailed history of Parkman Healthcare Partners LLC transactions in 908 Devices Inc. stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 100,368 shares of MASS stock, worth $550,016. This represents 0.11% of its overall portfolio holdings.

Number of Shares
100,368
Previous 100,000 0.37%
Holding current value
$550,016
Previous $713,000 23.28%
% of portfolio
0.11%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$5.44 - $8.76 $2,001 - $3,223
368 Added 0.37%
100,368 $879,000
Q2 2025

Aug 14, 2025

BUY
$3.63 - $7.97 $363,000 - $797,000
100,000 New
100,000 $713,000
Q2 2022

Aug 12, 2022

SELL
$13.3 - $20.74 $341,610 - $532,706
-25,685 Reduced 14.68%
149,315 $3.07 Million
Q1 2022

May 13, 2022

BUY
$13.18 - $26.28 $2.31 Million - $4.6 Million
175,000 New
175,000 $3.33 Million

Others Institutions Holding MASS

About 908 Devices Inc.


  • Ticker MASS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,590,200
  • Market Cap $173M
  • Description
  • 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...
More about MASS
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.